查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1825672

2025年全球臨床診斷市場報告

Clinical Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年臨床診斷市場將強勁成長，到2029年將達到1,079.2億美元，複合年成長率為7.2%。預測期內成長的主要驅動力包括：早期疾病檢測需求的不斷成長、醫療基礎設施的不斷擴大、研發投入的不斷增加、分子診斷需求的不斷成長以及文明病的患病率的不斷上升。預測期內的主要趨勢包括技術進步、數位病理學、人工智慧、穿戴式醫療設備和遠端醫療。

未來五年7.2%的成長率預測比我們先前的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能對美國醫療保健構成挑戰，因為它限制了美國從法國和瑞典進口的自動診斷工作站和分子檢測試劑盒的獲取，這可能導致診斷延遲和檢測服務成本上升。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，關稅的影響也可能更加廣泛。

慢性病盛行率的上升預計將推動臨床診斷市場的成長。慢性病需要持續的醫療管理，不健康的生活方式、社會經濟差距和人口老化往往會加劇其病情。這些疾病包括心臟病、糖尿病和癌症。準確的診斷、疾病監測、治療管理、併發症的早期發現、個人化醫療、風險評估和病患教育正變得越來越重要。例如，美國國家生物技術資訊中心 (NCBI) 預測，到 2050 年，50 歲及以上慢性病患者數量將增加 99.5%，從 2020 年的 7,152 萬增加到 1.4266 億人。盛行率的上升刺激了對臨床診斷的需求。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球臨床診斷：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球臨床診斷市場：成長率分析
  • 全球臨床診斷市場表現：規模與成長，2019-2024
  • 全球臨床診斷市場預測：規模與成長，2024-2029年，2034年
  • 全球臨床診斷：總目標市場（TAM）

第6章 市場細分

  • 全球臨床診斷市場：按測試、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 實驗室測試
  • 影像檢查
  • 其他測試
  • 全球臨床診斷市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 裝置
  • 試劑
  • 其他產品
  • 全球臨床診斷市場：按最終用戶、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院檢查室
  • 診斷實驗室
  • 就地檢驗
  • 其他最終用戶
  • 全球臨床診斷市場：按實驗室測試類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 血液檢查
  • 尿液檢查
  • 基因檢測
  • 切片檢查和細胞學檢測
  • 全球臨床診斷市場：影像檢查類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • X光
  • MRI（磁振造影）
  • 電腦斷層掃描（電腦斷層掃描）
  • 超音波
  • PET掃描（正子斷層掃描）
  • 全球臨床診斷市場：細分：其他測試（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 分子診斷
  • 就地檢驗
  • 妊娠試驗
  • 過敏測試

第7章 區域和國家分析

  • 全球臨床診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球臨床診斷市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 臨床診斷市場：競爭格局
  • 臨床診斷市場：公司簡介
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • FUJIFILM Corporation
  • Becton, Dickinson and Company
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Grifols SA
  • Sonic Healthcare Limited
  • Hologic Inc.
  • Illumina Inc.
  • PerkinElmer Inc.
  • bioMerieux SA
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • QIAGEN NV
  • Ortho Clinical Diagnostics

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年臨床診斷市場：提供新機會的國家
  • 2029年臨床診斷市場：細分領域帶來新機會
  • 2029年臨床診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r29795u

Clinical diagnostics involves the identification, diagnosis, and monitoring of diseases or medical conditions through a variety of laboratory tests, imaging techniques, and other diagnostic tools. This process includes analyzing and interpreting patient samples, medical history, and clinical data to provide accurate and timely information essential for diagnosing, treating, and managing diseases.

The primary types of clinical diagnostic tests are lab tests, imaging tests, and other diagnostic procedures. Lab tests are performed on samples such as blood, urine, or tissue to detect diseases, monitor health conditions, or assess the effectiveness of treatments. The products used in clinical diagnostics consist of instruments, reagents, and other related items. These diagnostic tools are employed by various end users, including hospital laboratories, diagnostic laboratories, point-of-care testing facilities, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The clinical diagnostics market research report is one of a series of new reports from The Business Research Company that provides clinical diagnostics market statistics, including clinical diagnostics industry global market size, regional shares, competitors with a clinical diagnostics market share, detailed clinical diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the clinical diagnostics industry. This clinical diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical diagnostics market size has grown strongly in recent years. It will grow from $76.27 billion in 2024 to $81.74 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to a rise in the incidence of chronic diseases, a rise in the use of point-of-care diagnostic products, an increasing number of tests due to the steady increase in patients, funding by governments, increasing demand for personalized medicine, and increasing geriatric population.

The clinical diagnostics market size is expected to see strong growth in the next few years. It will grow to $107.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing demand for early disease detection, expanding healthcare infrastructure, increasing investments in research and development, growing demand for molecular diagnostics, and rising prevalence of lifestyle-related diseases. Major trends in the forecast period include technological advancements, digital pathology, artificial intelligence, wearable health devices, and telemedicine.

The forecast of 7.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose challenges for U.S. healthcare by restricting access to automated diagnostic workstations and molecular testing cartridges imported from France and Sweden, potentially delaying diagnoses and increasing lab service costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of chronic diseases is expected to drive growth in the clinical diagnostics market. Chronic diseases, which require ongoing medical management and are often worsened by unhealthy lifestyles, socioeconomic disparities, and aging populations, include conditions such as heart disease, diabetes, and cancer. Accurate diagnosis, disease monitoring, treatment management, early detection of complications, personalized medicine, risk assessment, and patient education are becoming increasingly critical. For instance, the National Center for Biotechnology Information (NCBI) has projected that the number of individuals aged 50 and above with chronic illnesses will increase by 99.5% by 2050, growing from 71.52 million in 2020 to 142.66 million. This rising incidence is fueling the demand for clinical diagnostics.

Key players in the clinical diagnostics market are focusing on innovative products, such as advanced liquid biopsy assays, which facilitate comprehensive genomic profiling of solid tumors. Liquid biopsy assays are minimally invasive tests that analyze blood samples to identify cancer-related biomarkers, including circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA). These assays offer valuable insights for diagnosis, treatment monitoring, and personalized medicine. For example, in November 2023, Illumina Inc. introduced the TruSight(TM) Oncology 500 ctDNA v2, a liquid biopsy assay designed to provide detailed genomic profiling of solid tumors. This assay enables precise detection of genetic mutations and alterations, enhancing personalized treatment strategies by offering comprehensive molecular profiles and supporting timely clinical decisions.

In May 2022, BioMerieux acquired Specific Diagnostics to bolster its rapid antimicrobial susceptibility testing capabilities. This acquisition aims to strengthen BioMerieux's role in addressing antimicrobial resistance and improving patient outcomes in clinical microbiology. Specific Diagnostics, based in the US, is known for its innovations in clinical diagnostics, particularly in microbiology.

Major companies operating in the clinical diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, FUJIFILM Corporation, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Grifols S.A., Sonic Healthcare Limited, Hologic Inc., Illumina Inc., PerkinElmer Inc., bioMerieux S.A., Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Ortho Clinical Diagnostics, BioReference Laboratories Inc., NeoGenomics Laboratories Inc.

North America was the largest region in the clinical diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical diagnostics market includes revenues earned by entities by providing services such as genetic testing, molecular diagnostics, pathology services, microbiology testing, and immunology testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The clinical diagnostics market also includes sale of imaging devices, laboratory analyzers, point-of-care testing devices, endoscopy equipment, and respiratory diagnostic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test: Lab Test; Imaging Test; Other Tests
  • 2) By Product: Instruments; Reagents; Other Products
  • 3) By End User: Hospital Laboratory; Diagnostic Laboratory; Point-Of-Care Testing; Other End Users
  • Subsegments:
  • 1) By Lab Test: Blood Tests; Urine Tests; Genetic Tests; Biopsy And Cytology Tests
  • 2) By Imaging Test: X-Ray; Mri (Magnetic Resonance Imaging); Ct Scan (Computed Tomography); Ultrasound; Pet Scan (Positron Emission Tomography)
  • 3) By Other Tests: Molecular Diagnostics; Point-Of-Care Tests; Pregnancy Tests; Allergy Tests
  • Companies Mentioned: Siemens Healthineers; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; FUJIFILM Corporation; Becton, Dickinson and Company; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Grifols S.A.; Sonic Healthcare Limited; Hologic Inc.; Illumina Inc.; PerkinElmer Inc.; bioMerieux S.A.; Sysmex Corporation; Bio-Rad Laboratories Inc.; Bruker Corporation; QIAGEN N.V.; Ortho Clinical Diagnostics; BioReference Laboratories Inc.; NeoGenomics Laboratories Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Diagnostics Market Characteristics

3. Clinical Diagnostics Market Trends And Strategies

4. Clinical Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Clinical Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Clinical Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Clinical Diagnostics Market Growth Rate Analysis
  • 5.4. Global Clinical Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Clinical Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Clinical Diagnostics Total Addressable Market (TAM)

6. Clinical Diagnostics Market Segmentation

  • 6.1. Global Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lab Test
  • Imaging Test
  • Other Tests
  • 6.2. Global Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents
  • Other Products
  • 6.3. Global Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Laboratory
  • Diagnostic Laboratory
  • Point-Of-Care Testing
  • Other End Users
  • 6.4. Global Clinical Diagnostics Market, Sub-Segmentation Of Lab Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Tests
  • Urine Tests
  • Genetic Tests
  • Biopsy And Cytology Tests
  • 6.5. Global Clinical Diagnostics Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • X-Ray
  • MRI (Magnetic Resonance Imaging)
  • CT Scan (Computed Tomography)
  • Ultrasound
  • PET Scan (Positron Emission Tomography)
  • 6.6. Global Clinical Diagnostics Market, Sub-Segmentation Of Other Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Diagnostics
  • Point-Of-Care Tests
  • Pregnancy Tests
  • Allergy Tests

7. Clinical Diagnostics Market Regional And Country Analysis

  • 7.1. Global Clinical Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Clinical Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Clinical Diagnostics Market

  • 8.1. Asia-Pacific Clinical Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Clinical Diagnostics Market

  • 9.1. China Clinical Diagnostics Market Overview
  • 9.2. China Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Clinical Diagnostics Market

  • 10.1. India Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Clinical Diagnostics Market

  • 11.1. Japan Clinical Diagnostics Market Overview
  • 11.2. Japan Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Clinical Diagnostics Market

  • 12.1. Australia Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Clinical Diagnostics Market

  • 13.1. Indonesia Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Clinical Diagnostics Market

  • 14.1. South Korea Clinical Diagnostics Market Overview
  • 14.2. South Korea Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Clinical Diagnostics Market

  • 15.1. Western Europe Clinical Diagnostics Market Overview
  • 15.2. Western Europe Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Clinical Diagnostics Market

  • 16.1. UK Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Clinical Diagnostics Market

  • 17.1. Germany Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Clinical Diagnostics Market

  • 18.1. France Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Clinical Diagnostics Market

  • 19.1. Italy Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Clinical Diagnostics Market

  • 20.1. Spain Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Clinical Diagnostics Market

  • 21.1. Eastern Europe Clinical Diagnostics Market Overview
  • 21.2. Eastern Europe Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Clinical Diagnostics Market

  • 22.1. Russia Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Clinical Diagnostics Market

  • 23.1. North America Clinical Diagnostics Market Overview
  • 23.2. North America Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Clinical Diagnostics Market

  • 24.1. USA Clinical Diagnostics Market Overview
  • 24.2. USA Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Clinical Diagnostics Market

  • 25.1. Canada Clinical Diagnostics Market Overview
  • 25.2. Canada Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Clinical Diagnostics Market

  • 26.1. South America Clinical Diagnostics Market Overview
  • 26.2. South America Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Clinical Diagnostics Market

  • 27.1. Brazil Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Clinical Diagnostics Market

  • 28.1. Middle East Clinical Diagnostics Market Overview
  • 28.2. Middle East Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Clinical Diagnostics Market

  • 29.1. Africa Clinical Diagnostics Market Overview
  • 29.2. Africa Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Clinical Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Clinical Diagnostics Market Competitive Landscape
  • 30.2. Clinical Diagnostics Market Company Profiles
    • 30.2.1. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Clinical Diagnostics Market Other Major And Innovative Companies

  • 31.1. FUJIFILM Corporation
  • 31.2. Becton, Dickinson and Company
  • 31.3. Laboratory Corporation of America Holdings
  • 31.4. Quest Diagnostics Incorporated
  • 31.5. Grifols S.A.
  • 31.6. Sonic Healthcare Limited
  • 31.7. Hologic Inc.
  • 31.8. Illumina Inc.
  • 31.9. PerkinElmer Inc.
  • 31.10. bioMerieux S.A.
  • 31.11. Sysmex Corporation
  • 31.12. Bio-Rad Laboratories Inc.
  • 31.13. Bruker Corporation
  • 31.14. QIAGEN N.V.
  • 31.15. Ortho Clinical Diagnostics

32. Global Clinical Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Diagnostics Market

34. Recent Developments In The Clinical Diagnostics Market

35. Clinical Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Clinical Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Clinical Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Clinical Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer